Altered age‐linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT‐preAD study) with high brain amyloid load

INTRODUCTION: An effective therapy has not yet been developed for Alzheimer's disease (AD), in part because pathological changes occur years before clinical symptoms manifest. We recently showed that decreased plasma DYRK1A identifies individuals with mild cognitive impairment (MCI) or AD, and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (N Y)
Main Authors: Delabar, Jean M., Ortner, Marion, Simon, Stephanie, Wijkhuisen, Anne, Feraudet‐Tarisse, Cecile, Pegon, Jonathan, Vidal, Emma, Hirschberg, Yael, Dubois, Bruno, Potier, Marie‐Claude
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331462/
https://ncbi.nlm.nih.gov/pubmed/32642550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12046
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares